IL-21 Receptor is Required for the Systemic Accumulation of Activated B and T Lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J Mice
Overview
Authors
Affiliations
MRL/MpJ-Fas(lpr/lpr)/J (MRL(lpr)) mice develop lupus-like disease manifestations in an IL-21-dependent manner. IL-21 is a pleiotropic cytokine that can influence the activation, differentiation, and expansion of B and T cell effector subsets. Notably, autoreactive CD4(+) T and B cells spontaneously accumulate in MRL(lpr) mice and mediate disease pathogenesis. We sought to identify the particular lymphocyte effector subsets regulated by IL-21 in the context of systemic autoimmunity and, thus, generated MRL(lpr) mice deficient in IL-21R (MRL(lpr).IL-21R(-/-)). Lymphadenopathy and splenomegaly, which are characteristic traits of the MRL(lpr) model were significantly reduced in the absence of IL-21R, suggesting that immune activation was likewise decreased. Indeed, spontaneous germinal center formation and plasma cell accumulation were absent in IL-21R-deficient MRL(lpr) mice. Correspondingly, we observed a significant reduction in autoantibody titers. Activated CD4(+) CD44(+) CD62L(lo) T cells also failed to accumulate, and CD4(+) Th cell differentiation was impaired, as evidenced by a significant reduction in CD4(+) T cells that produced the pronephritogenic cytokine IFN-γ. T extrafollicular helper cells are a recently described subset of activated CD4(+) T cells that function as the primary inducers of autoantibody production in MRL(lpr) mice. Importantly, we demonstrated that T extrafollicular helper cells are dependent on IL-21R for their generation. Together, our data highlighted the novel observation that IL-21 is a critical regulator of multiple pathogenic B and T cell effector subsets in MRL(lpr) mice.
IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials.
Koh C, Kim B, Kang C, Chung Y, Seo H Immune Netw. 2024; 24(1):e2.
PMID: 38455465 PMC: 10917578. DOI: 10.4110/in.2024.24.e2.
AP-1-independent NFAT signaling maintains follicular T cell function in infection and autoimmunity.
Seth A, Yokokura Y, Choi J, Shyer J, Vidyarthi A, Craft J J Exp Med. 2023; 220(5).
PMID: 36820828 PMC: 9998660. DOI: 10.1084/jem.20211110.
Composition and regulation of the immune microenvironment of salivary gland in Sjögren's syndrome.
Tan Z, Wang L, Li X Front Immunol. 2022; 13:967304.
PMID: 36177010 PMC: 9513852. DOI: 10.3389/fimmu.2022.967304.
Valentine K, Mullins G, Davalos O, Seow L, Hoyer K J Autoimmun. 2021; 123:102690.
PMID: 34274825 PMC: 9374523. DOI: 10.1016/j.jaut.2021.102690.
The Potential of Harnessing IL-2-Mediated Immunosuppression to Prevent Pathogenic B Cell Responses.
Papillion A, Ballesteros-Tato A Front Immunol. 2021; 12:667342.
PMID: 33986755 PMC: 8112607. DOI: 10.3389/fimmu.2021.667342.